நாட்கோ பார்மா பகிர் ப்ரைஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நாட்கோ பார்மா பகிர் ப்ரைஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நாட்கோ பார்மா பகிர் ப்ரைஸ் Today - Breaking & Trending Today

Natco Pharma share price: Buy Natco Pharma, target price Rs 1150: Kotak Securities

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 19969.64 Crore) operating in Pharmaceuticals sector. ....

Natco Pharma Share Price , Stocks To Buy , Natco Pharma Ltd , Market News , நாட்கோ பார்மா பகிர் ப்ரைஸ் , ஸ்டாக்ஸ் க்கு வாங்க , சந்தை செய்தி ,

Natco Pharma shares hit upper circuit. Here's why

Natco Pharma shares hit upper circuit. Here s why
SECTIONS
Last Updated: May 24, 2021, 11:36 AM IST
Share
Synopsis
The Hyderabad-based firm said the first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals.
Agencies
INSIGHTS
NSE
Explore Now
NEW DELHI: Natco Pharma shares hit the upper circuit on Monday after the company initiated phase-III clinical trials of Molnupiravir capsules to evaluate its efficacy in treating patients with mild Covid-19.
The first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals, the Hyderabad-based firm said in a regulatory filing.
The scrip hit the 20 per cent upper circuit to touch the Rs 1,188.95-mark in the first half of the session. However, the rally fizzled out soon, with the stock returning to Rs 1,097.20, up 11 per cent for the day. ....

Andhra Pradesh , Natco Pharma , Drug Administration , Yashoda Hospitals , Natco Pharma Shares , Natco Pharma Share Price , Covid Vaccine , Natco Pharma Stock Price , ஆந்திரா பிரதேஷ் , நாட்கோ பார்மா , யஷோட மருத்துவமனைகள் , நாட்கோ பார்மா பகிர் ப்ரைஸ் ,

Natco Pharma surges 20%, hits new high on USFDA nod for cancer drug

Shares of Natco Pharma surged 20 per cent to Rs 1,188.95, also its new high, on the BSE in intra-day trade on Monday after the company said it has received approval from the US health regulator for the generic version of Celgene s multiple myeloma drug, Revlimid (Lenalidomide) capsules in US. Lenalidomide capsule is indicated for treatment of adults with multiple myeloma, mantle cell lymphoma and myelodysplastic syndromes.
In the past three days, the stock has zoomed 30 per cent. At 09:48 am, Natco Pharma was trading 11 per cent higher at Rs 1,101 on the BSE, as compared to 0.24 per cent rise in the S&P BSE Sensex. The trading volumes on the counter jumped over five-fold with a combined 3.8 million equity shares changing hands on the NSE and BSE. ....

Andhra Pradesh , Revlimid Lenalidomide , Natco Pharma , Drug Administration , Breckenridge Pharmaceutical Inc , Abbreviated New Drug Application , Molnupiravir Capsules , Yashoda Hospitals , Gleneagles Global Hospitals , Excel Hospital , Natco Pharma Share Price , Elgene S , Natco Pharma , Atco Pharma Latest News , ஆந்திரா பிரதேஷ் , நாட்கோ பார்மா , ப்ரெக்கன்ரிட்ஜ் மருந்து இன்க் , யஷோட மருத்துவமனைகள் , க்ல்நேயேஜ்ல்ஸ் உலகளாவிய மருத்துவமனைகள் , எக்செல் மருத்துவமனை , நாட்கோ பார்மா பகிர் ப்ரைஸ் ,

Natco Pharma Share Price: Covid-19 Medicine News: Natco Pharma Gains Over 4% On Getting Emergency Use Approval Of COVID-19 Medicine

Natco Pharma shares rose as much as 4.27%
Shares of the Hyderabad-based Natco Pharma gained as much as 4.27 per cent to hit an intraday high of Rs 935 after it received emergency use approval for drug to treat COVID-19 positive patients.
Natco Pharma Limited has received emergency use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India. Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients, the company said in a press release.
COVID-19 drugs like Remdesivir are in huge shortage owing to rising number of Covid-19 infections in the country. On Monday, India s active caseload passed the 34 lakh-mark with 3,68,147 fresh infections added in the last 24 hours, six per cent lower than yesterday s spike. Over 3,417 Covid-linked deaths have been reported since yesterday, taking total deaths to 2,18,959. ....

Natco Pharma , Central Drugs Standard Control Organization , Hyderabad Based Natco Pharma , Pharma Limited , Natco Pharma Share Price , Covid 19 Drug , Covid 19 Medicine , Corona Medicine , Natco Pharma News Today , Natco Pharma Shares , Share Market News , நாட்கோ பார்மா , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , ஹைதராபாத் அடிப்படையிலானது நாட்கோ பார்மா , பார்மா வரையறுக்கப்பட்டவை , நாட்கோ பார்மா பகிர் ப்ரைஸ் , கொரோனா மருந்து , பகிர் சந்தை செய்தி ,

Natco Pharma share price live today - Why Natco Pharma share price is up by 3.13% today? Natco Pharma share price analysis

PE Ratio
This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.(x)34.97
EPS - TTM
EPS - TTM
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.(₹)26.43
MCap
MCap
MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.(₹ Cr.)16,343.85 ....

Natco Pharma , Quarterly Topline , Consolidated Financials , Spinning Top , Nifty Midcap , Natco Pharma Share Price , Atco Pharma Share Price Today , Atco Pharma Share Price Live , Natco Pharma Stock Price , Atco Pharma Share Price Analysis , Atco Pharma Stock Price News , நாட்கோ பார்மா , தொகுக்கப்பட்டு நிதி , நூற்பு மேல் , நாட்கோ பார்மா பகிர் ப்ரைஸ் ,